Brasília – Brazil establishes its first specific regulation governing the use of artificial intelligence in medicine, determining that AI systems may function only as clinical support tools and cannot issue automated diagnoses directly to patients. The Federal Council of Medicine (Conselho Federal de Medicina) publishes a resolution stating that diagnoses, prognoses and therapeutic decisions remain the exclusive responsibility of licensed physicians.

Under the new rule, doctors must inform patients when AI tools are used in their care, and patients have the right to refuse the use of such technologies. The measure seeks to balance technological innovation with patient safety, ethical standards and professional accountability. The resolution enters into force 180 days after its publication.

Source: G1


Need to understand Brazil’s market and political landscape?

Contact Pietro Rubin pharmabrnews@gmail.com


Leave a Reply

Tendência

Discover more from PharmaBR.News

Subscribe now to keep reading and get access to the full archive.

Continue reading